Elsevier, Biological Psychiatry, 6(73), p. 518-524, 2013
DOI: 10.1016/j.biopsych.2012.06.019
Full text: Unavailable
Transcranial magnetic stimulation (TMS) is a novel therapeutic approach, used in patients with pharmacoresistant auditory verbal hallucinations (AVH). To investigate the neurobiological effects of TMS on AVH, we measured cerebral blood flow with pseudo-continuous magnetic resonance-arterial spin labeling 20 ± 6 hours before and after TMS treatment.